ORIGINAL ARTICLE

Clopidogrel use After Myocardial Revascularization: Prevalence, Predictors, and One-Year Survival Rate

Paulo Roberto L. Prates^I,^II; Judson B. Williams^III,^IV; Rajendra H. Mehta^V,^VI; Susanna R. Stevens^VII; Laine Thomas^VIII; Peter K. Smith^III; L. Kristin Newby^IV,^IX; Renato A. K. Kalil^X,^XI; John H. Alexander^XII,^XIII; Renato D. Lopes^XIV,^XV

DOI: 10.5935/1678-9741.20160019

^IMD. Department of Cardiovascular Surgery, Instituto de Cardiologia-Fundação Universitária de Cardiologia, Porto Alegre, RS, Brazil
^IIMD. Clinical Research Center - Instituto de Cardiologia-Fundação Universitária de Cardiologia, Porto Alegre, RS, Brazil
^IIIMD. Department of Surgery, Division of Cardiovascular and Thoracic Surgery, Duke University Medical Center, Durham, NC
^IVMD. Department of Medicine, Division of Cardiology, Duke University Medical Center, Durham, NC
^VMD, MSc. Department of Medicine, Division of Cardiology, Duke University Medical Center, Durham, NC
^VIMD, MSc. Duke Clinical Research Institute, Durham, NC
^VIIMSc. Duke Clinical Research Institute, Durham, NC
^VIIIPhD. Duke Clinical Research Institute, Durham, NC
^IXMD. Duke Clinical Research Institute, Durham, NC
^XMD, PhD. Department of Cardiovascular Surgery, Instituto de Cardiologia-Fundação Universitária de Cardiologia, Porto Alegre, RS, Brazil
^XIMD, PhD. Clinical Research Center - Instituto de Cardiologia-Fundação Universitária de Cardiologia, Porto Alegre, RS, Brazil
^XIIMD, MHS. Department of Medicine, Division of Cardiology, Duke University Medical Center, Durham, NC
^XIIIMD, MHS. Duke Clinical Research Institute, Durham, NC
^XIVMD, PhD. Department of Medicine, Division of Cardiology, Duke University Medical Center, Durham, NC
^XVMD, PhD. Duke Clinical Research Institute, Durham, NC

Correspondence
Renato D. Lopes Duke Clinical Research Institute, Box 3850, 2400 Pratt Street, Room 0311 Terrace Level Durham, NC 27705 E-mail: renato.lopes@duke.edu